Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy

NCT02523183 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02523183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02523183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2015
Completion date
November 30, 2020
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, unspecified, refractory (medically)